Carrie Mosley
Family · Bakersfield, CANPI 1336190933
Payments from drug & device makers
Across 509 payments — averaging $21.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$3K
- AstraZeneca$2K
- Boehringer Ingelheim$1K
- Actelion Pharmaceuticals US, Inc.$712
- Sanofi$539
- Merck$388
- plus $3K from 28 others
What the payments were for
- Food & beverage$10,929100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 173 | $3,064 |
| AstraZeneca | 80 | $1,664 |
| Boehringer Ingelheim | 64 | $1,350 |
| Actelion Pharmaceuticals US, Inc. | 29 | $712 |
| Sanofi | 24 | $539 |
| Merck | 10 | $388 |
| United Therapeutics Corporation | 14 | $366 |
| Verona Pharma, Inc. | 12 | $342 |
| Grifols USA, LLC | 13 | $337 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $250 |
| Regeneron Healthcare Solutions, Inc. | 10 | $240 |
| Insmed, Inc. | 6 | $238 |
| Baxter Healthcare | 10 | $234 |
| Electromed, Inc. | 10 | $198 |
| Pfizer | 9 | $181 |
| Mylan Specialty L.p. | 7 | $159 |
| Novartis | 6 | $150 |
| Amgen | 5 | $106 |
| Silk Road Medical, Inc. | 1 | $80 |
| Tactile Systems Technology Inc | 1 | $36 |
| Viatris Specialty LLC | 2 | $36 |
| Genentech USA, Inc. | 1 | $31 |
| Advanced Respiratory, Inc | 1 | $28 |
| Optinose US, Inc. | 1 | $26 |
| Lilly USA, LLC | 2 | $26 |
| Alk-abello, Inc | 1 | $21 |
| Nabriva Therapeutics, PLC | 1 | $19 |
| AbbVie | 1 | $19 |
| Mayne Pharma Commercial LLC | 1 | $19 |
| Gilead | 1 | $16 |
| Exact Sciences | 1 | $16 |
| Smith+Nephew | 1 | $15 |
| Bayer | 1 | $15 |
| Johnson & Johnson | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUCALA$625
- TRELEGY ELLIPTA$125
- WINREVAIR$125
- BREZTRI$125
- DUPIXENT$100
How this compares
$10,929 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 198 | $161,049 |
| Breo ElliptaFluticasone/Vilanterol | 62 | $30,765 |
| Spiriva RespimatTiotropium Bromide | 33 | $22,398 |
| MounjaroTirzepatide | 24 | $21,146 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 25 | $16,983 |
| FarxigaDapagliflozin Propanediol | 13 | $8,658 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 184 | $6,999 |
| MyrbetriqMirabegron | 13 | $6,553 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 12 | $6,444 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 22 | $4,033 |
| DuleraMometasone/Formoterol | 12 | $3,941 |
| Arnuity ElliptaFluticasone Furoate | 16 | $3,794 |
| Pulmicort FlexhalerBudesonide | 12 | $3,670 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 11 | $3,096 |
| Doxepin Hcl | 11 | $2,460 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $3,064 | $195,607276 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Pulmicort Flexhaler | $1,664 | $29,31150 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat | $1,350 | $28,84345 claims |
| Lilly USA, LLCMounjaro | $26 | $21,14624 claims |
| MerckDulera, Janumet Xr | $388 | $7,03723 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,634 family providers in California.
Other family in Bakersfield
- Jennifer TougasBakersfield$302K
- Ashton ChaseBakersfield$86K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.